JAKi for Dermatomyositis
Dermatomyositis (DM) is a systemic autoimmune rheumatic disease which can affect multi-organs, such as skin, muscle and lung. Five myositis-specific autoantibodies, i.e., TIF1r, MDA5, NXP2, Mi2 and SAE, are sero-markers of diagnostic value. The treatments for DM included glucocorticoids, csDMARDs, I...
Saved in:
| Main Author: | Shuang Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2024-01-01
|
| Series: | Journal of Clinical Rheumatology and Immunology |
| Online Access: | https://www.worldscientific.com/doi/10.1142/S266134172474016X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unlocking JAKi Potential: Redefining Axial Spondyloarthritis Treatment Paradigms
by: Andrew Östör
Published: (2024-01-01) -
W jaki sposób forma muzyczna staje się gatunkiem literackim
by: Łukasz Piaskowski
Published: (2023-06-01) -
Spontaneous pneumomediastinum in dermatomyositis
by: Ankit Jain, et al.
Published: (2017-01-01) -
Juvenile Dermatomyositis in Pregnancy
by: Anthony Emeka Madu, et al.
Published: (2013-01-01) -
Dyslipidemia in Juvenile Dermatomyositis
by: Amer Khojah, et al.
Published: (2024-11-01)